Aribamed partners with Cheplapharm in Anaesthesia
Aribamed and Cheplapharm GmBH have agreed to market Anexate(flumazenil) to Hospital specialists in Ireland. Aribamed is Cheplapharm's exclusive partner and the companies are targetting additional important medicines for promotion later in the year. We are delighted to be working with Cheplapharm said Matt Shanahan, Chief Operations Officer. This partnership strengthens our franchise in anaesthesia and critical care.